| Hospice Of Southwest Georgia 114 A Mimosa Drive, Thomasville, GA, 31792 | |
| (229) 584-5500 |
News Archive
Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Norethindrone Tablets USP, 0.35 mg.
Scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and the Stein Eye Institute have been awarded a $5.1 million grant from the California Institute for Regenerative Medicine to advance the development of a novel therapy for blinding retinal conditions.
New work from the Broad Institute's Klarman Cell Observatory, Brigham and Women's Hospital, Harvard University, MIT, and Yale University expands the understanding of how one type of immune cell - known as a T helper 17 or Th17 cell - develops, and how its growth influences the development of immune responses.
Health Affairs: What Changes In Survival Rates Tell Us About US Health Care - Proponents of changes in the U.S. health system have often pointed to studies that find health outcomes in this country are worse than other developed nations, even though the United States "spends well over twice the median expenditure of industrialized nations on health care, and far more than any other country as a percentage of its gross domestic product." Others point to high rates of smoking, obesity and traffic fatalities.
› Verified 6 days ago
| Name | Hospice Of Southwest Georgia |
|---|---|
| Location | 114 A Mimosa Drive, Thomasville, Georgia |
| Hospice ID | 111521 |
| Category | Freestanding Hospice |
| Ownership Type | Voluntary Non-profit - Private |
| Profit Type | NON-PROFIT |
| SSA county code | 890 |
News Archive
Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Norethindrone Tablets USP, 0.35 mg.
Scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and the Stein Eye Institute have been awarded a $5.1 million grant from the California Institute for Regenerative Medicine to advance the development of a novel therapy for blinding retinal conditions.
New work from the Broad Institute's Klarman Cell Observatory, Brigham and Women's Hospital, Harvard University, MIT, and Yale University expands the understanding of how one type of immune cell - known as a T helper 17 or Th17 cell - develops, and how its growth influences the development of immune responses.
Health Affairs: What Changes In Survival Rates Tell Us About US Health Care - Proponents of changes in the U.S. health system have often pointed to studies that find health outcomes in this country are worse than other developed nations, even though the United States "spends well over twice the median expenditure of industrialized nations on health care, and far more than any other country as a percentage of its gross domestic product." Others point to high rates of smoking, obesity and traffic fatalities.
› Verified 6 days ago
| NPI Number | 1326026782 |
| Organization Name | Archbold Health Services, Inc. |
| Address | 114 A Mimosa Dr Thomasville, Georgia, 31792 |
| Phone Number | (229)584-5501 |
News Archive
Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Norethindrone Tablets USP, 0.35 mg.
Scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and the Stein Eye Institute have been awarded a $5.1 million grant from the California Institute for Regenerative Medicine to advance the development of a novel therapy for blinding retinal conditions.
New work from the Broad Institute's Klarman Cell Observatory, Brigham and Women's Hospital, Harvard University, MIT, and Yale University expands the understanding of how one type of immune cell - known as a T helper 17 or Th17 cell - develops, and how its growth influences the development of immune responses.
Health Affairs: What Changes In Survival Rates Tell Us About US Health Care - Proponents of changes in the U.S. health system have often pointed to studies that find health outcomes in this country are worse than other developed nations, even though the United States "spends well over twice the median expenditure of industrialized nations on health care, and far more than any other country as a percentage of its gross domestic product." Others point to high rates of smoking, obesity and traffic fatalities.
› Verified 6 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 98.3 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 91.5 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 93.5 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 65.2 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 94.6 | 97.3 |
| Patients who got timely treatment for shortness of breath | 83.1 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 67.6 | 93.3 |
News Archive
Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Norethindrone Tablets USP, 0.35 mg.
Scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and the Stein Eye Institute have been awarded a $5.1 million grant from the California Institute for Regenerative Medicine to advance the development of a novel therapy for blinding retinal conditions.
New work from the Broad Institute's Klarman Cell Observatory, Brigham and Women's Hospital, Harvard University, MIT, and Yale University expands the understanding of how one type of immune cell - known as a T helper 17 or Th17 cell - develops, and how its growth influences the development of immune responses.
Health Affairs: What Changes In Survival Rates Tell Us About US Health Care - Proponents of changes in the U.S. health system have often pointed to studies that find health outcomes in this country are worse than other developed nations, even though the United States "spends well over twice the median expenditure of industrialized nations on health care, and far more than any other country as a percentage of its gross domestic product." Others point to high rates of smoking, obesity and traffic fatalities.
› Verified 6 days ago
| Home Health Aides | 2 |
| Counselors | 2 |
| Licensed Practical or Vocational Nurses | 1 |
| Medical Social Workers | 1 |
| Registered Nurses | 6 |
| Other Personnel | 6 |
| Total Employees | 18 |
|---|
News Archive
Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Norethindrone Tablets USP, 0.35 mg.
Scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and the Stein Eye Institute have been awarded a $5.1 million grant from the California Institute for Regenerative Medicine to advance the development of a novel therapy for blinding retinal conditions.
New work from the Broad Institute's Klarman Cell Observatory, Brigham and Women's Hospital, Harvard University, MIT, and Yale University expands the understanding of how one type of immune cell - known as a T helper 17 or Th17 cell - develops, and how its growth influences the development of immune responses.
Health Affairs: What Changes In Survival Rates Tell Us About US Health Care - Proponents of changes in the U.S. health system have often pointed to studies that find health outcomes in this country are worse than other developed nations, even though the United States "spends well over twice the median expenditure of industrialized nations on health care, and far more than any other country as a percentage of its gross domestic product." Others point to high rates of smoking, obesity and traffic fatalities.
› Verified 6 days ago
| Hospice Of Southwest Georgia Location: 114 A Mimosa Drive, Thomasville, Georgia, 31792 Phone: (229) 584-5500 |